228 related articles for article (PubMed ID: 24188490)
1. Role of matrix metalloproteinases in animal models of ischemic stroke.
Lenglet S; Montecucco F; Mach F
Curr Vasc Pharmacol; 2015; 13(2):161-6. PubMed ID: 24188490
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
Morancho A; Rosell A; García-Bonilla L; Montaner J
Ann N Y Acad Sci; 2010 Oct; 1207():123-33. PubMed ID: 20955435
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.
Haorah J; Ramirez SH; Schall K; Smith D; Pandya R; Persidsky Y
J Neurochem; 2007 Apr; 101(2):566-76. PubMed ID: 17250680
[TBL] [Abstract][Full Text] [Related]
5. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Machado LS; Kozak A; Ergul A; Hess DC; Borlongan CV; Fagan SC
BMC Neurosci; 2006 Jul; 7():56. PubMed ID: 16846501
[TBL] [Abstract][Full Text] [Related]
6. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles for MMPs and TIMPs in cerebral ischemia.
Cunningham LA; Wetzel M; Rosenberg GA
Glia; 2005 Jun; 50(4):329-339. PubMed ID: 15846802
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update.
Florczak-Rzepka M; Grond-Ginsbach C; Montaner J; Steiner T
Cerebrovasc Dis; 2012; 34(4):249-62. PubMed ID: 23052179
[TBL] [Abstract][Full Text] [Related]
9. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS
J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948
[TBL] [Abstract][Full Text] [Related]
10. Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats.
Piao MS; Lee JK; Park CS; Ryu HS; Kim SH; Kim HS
Acta Neurochir (Wien); 2009 Dec; 151(12):1649-53. PubMed ID: 19551335
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.
McColl BW; Rothwell NJ; Allan SM
J Neurosci; 2008 Sep; 28(38):9451-62. PubMed ID: 18799677
[TBL] [Abstract][Full Text] [Related]
12. Multiphasic roles for matrix metalloproteinases after stroke.
Rosell A; Lo EH
Curr Opin Pharmacol; 2008 Feb; 8(1):82-9. PubMed ID: 18226583
[TBL] [Abstract][Full Text] [Related]
13. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
15. Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation.
Mattila OS; Strbian D; Saksi J; Pikkarainen TO; Rantanen V; Tatlisumak T; Lindsberg PJ
Stroke; 2011 Dec; 42(12):3600-5. PubMed ID: 21980200
[TBL] [Abstract][Full Text] [Related]
16. Role of matrix metalloproteinases in delayed cortical responses after stroke.
Zhao BQ; Wang S; Kim HY; Storrie H; Rosen BR; Mooney DJ; Wang X; Lo EH
Nat Med; 2006 Apr; 12(4):441-5. PubMed ID: 16565723
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment--Cooling matrix metalloproteinases to improve thrombolysis in acute ischemic stroke.
Montaner J
Stroke; 2003 Sep; 34(9):2171-2. PubMed ID: 12933975
[No Abstract] [Full Text] [Related]
18. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke.
Miller AA; Dusting GJ; Roulston CL; Sobey CG
Brain Res; 2006 Sep; 1111(1):111-6. PubMed ID: 16879806
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Ueno M; Wu B; Nishiyama A; Huang CL; Hosomi N; Kusaka T; Nakagawa T; Onodera M; Kido M; Sakamoto H
Hypertens Res; 2009 May; 32(5):332-8. PubMed ID: 19300451
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
